Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $715.25M.
ENTERPRISE VALUE (EV)
$715.25M
Jade Biosciences, Inc.
Market Cap
$803.69M
Enterprise Value (EV)
$715.25M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Jade Biosciences, Inc. (JBIO) | $803.69M | $715.25M |
| InMode Ltd. (INMD)vs › | $804.44M | $412.72M |
| Ardelyx, Inc. (ARDX)vs › | $802.13M | $961.13M |
| AdaptHealth Corp. (AHCO)vs › | $792.51M | $2.81B |
| Gyre Therapeutics, Inc. (GYRE)vs › | $789.31M | $749.44M |
| Geron Corporation (GERN)vs › | $785.86M | $845.36M |
| Pacific Biosciences of California, Inc. (PACB)vs › | $827.75M | $1.47B |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $830.54M | $778.43M |
| Beta Bionics, Inc. (BBNX)vs › | $830.96M | $793.15M |
| Alumis Inc. (ALMS)vs › | $834.31M | $807.04M |
Market Cap
$803.69M
Total Debt
$0.00
Cash
$88.44M
Enterprise Value
$715.25M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
